Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Notes Payables (2022 - 2025)

Intelligent Bio Solutions has reported Notes Payables over the past 3 years, most recently at $515282.0 for Q2 2024.

  • For Q2 2024, Notes Payables rose 45.89% year-over-year to $515282.0; the TTM value through Jun 2024 reached $515282.0, up 45.89%, while the annual FY2024 figure was $515282.0, 45.89% up from the prior year.
  • Notes Payables for Q2 2024 was $515282.0 at Intelligent Bio Solutions, up from $368513.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $523703.0 in Q4 2022 and troughed at $335528.0 in Q1 2023.
  • A 3-year average of $401229.4 and a median of $368513.0 in 2024 define the central range for Notes Payables.
  • Biggest five-year swings in Notes Payables: decreased 29.25% in 2023 and later soared 45.89% in 2024.
  • Year by year, Notes Payables stood at $523703.0 in 2022, then dropped by 29.25% to $370535.0 in 2023, then surged by 39.06% to $515282.0 in 2024.
  • Business Quant data shows Notes Payables for INBS at $515282.0 in Q2 2024, $368513.0 in Q1 2024, and $370535.0 in Q4 2023.